Jubilant DraxImage Inc. Report issue

For profit Phase 2
Founded: India (2008)
Status: Acquired by Jubilant Industries (2008) → now Jubilant Innovation Ltd. (1978)

Organization Overview

First Clinical Trial
2012
NCT01590680
First Marketed Drug
2008
sodium iodide i-131 (iodotope)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CIS | JUBILANT | Jubilant DraxIamge Inc. | JUBILANT DRAXIMAGE | Jubilant DraxImage Inc.